Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria

Paul Columba Inyang-Etoh; Offid Abosede Obi; Mfoniso Iniobong Udonkang

doi:10.5455/jmas.279731

2025, Vol: 15, Issue: 2

15 / 2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

« Previous Article

Original Article

J Med Allied Sci. 2018; 8(1): 17-21

doi: 10.5455/jmas.279731

Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria

Paul Columba Inyang-etoh, Offid Abosede Obi, Mfoniso Iniobong Udonkang.

Abstract
Co-infection of Human Immunodeficiency Virus/Acquired Immune Disease Syndrome (HIV/AIDS) with hepatitis is linked with amplified morbidity and mortality. This study was to investigate the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus (HDV) among patients on highly active antiretroviral drug therapy (HAART). A total of 200 subjects currently on HAART and 50 non-HIV positive individuals (control subjects) aged 10-75 years were recruited for the study. Hepatitis B surface antigen and hepatitis C viral antibodies were screened with ACON test strip while HDV was screened with human hepatitis D virus ELISA kit. Demographic data of subjects were obtained with questionnaires. Determination of the CD4 counts was done using the Cytoflow counter. Among the test subjects, prevalence of HBV infection was 16(8%), HCV was 6(3%), mixed infection with HBV and HCV was 2(1%), and HDV was 0(0%). Among the control subjects, infection with HBV was 6(12%), 4(8%) for HCV and none for HDV or mixed infection. There was no statistically significant difference (p=0.491). Males had a higher occurrence of HBV infection 9(11.4%) and HCV infection 4(5.1%) than the females who had 7(5.8%) for HBV and 2(1.6%) for HCV, but this was not statistically significant (p=0.0879). Subjects with CD4 count range of 1401-1600 had the highest occurrence 1(20%) for HBV and 1201-1400 range for HCV 1(8.3%) but the difference was not statistically significant (p=0.504). In conclusion, infection with HBV and HCV is widespread among patients on HAART and routine screening is advocated for efficient management of the disease.

Key words: Calabar, HAART, HBV, HCV, HDV, Prevalence

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Paul Columba Inyang-Etoh Articles by Offid Abosede Obi Articles by Mfoniso Iniobong Udonkang
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Inyang-etoh PC, Obi OA, Udonkang MI. Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. J Med Allied Sci. 2018; 8(1): 17-21. doi:10.5455/jmas.279731

Web Style

Inyang-etoh PC, Obi OA, Udonkang MI. Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. https://jmas.in/?mno=279731 [Access: June 23, 2026]. doi:10.5455/jmas.279731

AMA (American Medical Association) Style

Inyang-etoh PC, Obi OA, Udonkang MI. Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. J Med Allied Sci. 2018; 8(1): 17-21. doi:10.5455/jmas.279731

Vancouver/ICMJE Style

Inyang-etoh PC, Obi OA, Udonkang MI. Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. J Med Allied Sci. (2018), [cited June 23, 2026]; 8(1): 17-21. doi:10.5455/jmas.279731

Harvard Style

Inyang-etoh, P. C., Obi, . O. A. & Udonkang, . M. I. (2018) Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. J Med Allied Sci, 8 (1), 17-21. doi:10.5455/jmas.279731

Turabian Style

Inyang-etoh, Paul Columba, Offid Abosede Obi, and Mfoniso Iniobong Udonkang. 2018. Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. Journal of Medical and Allied Sciences, 8 (1), 17-21. doi:10.5455/jmas.279731

Chicago Style

Inyang-etoh, Paul Columba, Offid Abosede Obi, and Mfoniso Iniobong Udonkang. "Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria." Journal of Medical and Allied Sciences 8 (2018), 17-21. doi:10.5455/jmas.279731

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Inyang-etoh, P. C., Obi, . O. A. & Udonkang, . M. I. (2018) Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. Journal of Medical and Allied Sciences, 8 (1), 17-21. doi:10.5455/jmas.279731

About Journal of Medical and Allied Sciences

Contact Information

How to cite this article


About Journal of Medical and Allied Sciences Welcome to the Journal of Medical and Allied Sciences (JMAS), an official international publication of Deccan College of Medical Sciences, for rapid publi ... Read more. For best results, please use Internet Explorer or Google Chrome.	Contact Information By regular mail/speed post/courier Dr. Kazi Mudabbir Ahmed Editor, JMAS, Deccan College of Medical Sciences, DMRL ‘X’ Road, Kanchanbagh (PO), Hyderabad-500 058, Telangana, India. By email: editorialoffice@jmas.in By phone: +91 40 24340225, 24340129 By Mobile: +91-8522828349 By fax: +91 40 24340235